Year in Review: Follicular Lymphoma

(MedPage Today) -- Credit: Patho Studies demonstrating high response rates and manageable safety profiles, along with FDA approvals, have supported bispecific antibodies as promising treatment options for follicular lymphoma. At the start...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news